Challenging Barriers to Community Oncology Care
Dipti Patel-Donnelly, MD, highlights challenges for physicians and patients when managing treatment of hematologic malignancies in the community setting.
The potential of new cancer therapies like chimeric antigen receptor (CAR) T cells, bispecific antibodies, and antibody drug conjugates is exciting, but their accessibility remains a challenge. Many of these treatments are currently restricted to academic centers, leaving patients in local communities with fewer options.
At the American Society of Hematology 2023 Annual Meeting, Dipti Patel-Donnelly, MD, medical oncologist at Virginia Cancer Specialists, discussed challenges physicians and patients can face when treating hematologic malignancies in the community, as well as how to address these challenges through a co-management strategy.
Transcription:
0:09 |
PTCy Offers New Hope for Mismatched Stem Cell Transplants in Leukemia, MDS
April 13th 2024Jeff Auletta, MD, discussed how PTCy-based graft-vs-host disease prophylaxis offers a promising approach for expanding access to successful cell transplantation regardless of donor match or patient ethnicity.
Read More
